Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission

Author:

Weisdorf Daniel J.1,Millard Heather R.2,Horowitz Mary M.2,Hyare Parvinder S.3,Champlin Richard4,Ho Vincent5,Mielcarek Marco6,Rezvani Andrew7,Stockerl‐Goldstein Keith8,Khoury Hanna J.9,De Lima Marcos10,Saber Wael2,Sandmaier Brenda11,Zhang Mei Jie212,Eapen Mary2

Affiliation:

1. Division of HematologyOncology, and Transplantation, Department of Medicine, University of Minnesota Medical CenterMinneapolis Minnesota

2. Center for International Blood and Marrow Transplantation (CIBMTR)Department of Medicine, Medical College of WisconsinMilwaukee Wisconsin

3. Sunesis PharmaceuticalsSan Francisco California

4. Department of Stem Cell Transplantation and Cellular TherapyDivision of Cancer Medicine, The University of Texas MD Anderson Cancer CenterHouston Texas

5. Center for Hematologic OncologyDana‐Farber Cancer InstituteBoston Massachusetts

6. Adult Blood and Marrow Transplant ProgramFred Hutchinson Cancer Research Center, Seattle Cancer Care AllianceSeattle Washington

7. Division of Blood and Marrow TransplantationStanford Health CareStanford California

8. Division of Hematology/Oncology, Barnes Jewish HospitalSt. Louis Missouri

9. Hematology/OncologyEmory University School of Medicine, Emory University HospitalAtlanta Georgia

10. Department of MedicineSeidman Cancer Center, University Hospitals Case Medical CenterCleveland Ohio

11. Division of Medical OncologyUniversity of Washington and Clinical Research Division, Fred Hutchinson Cancer Research CenterSeattle Washington

12. Division of BiostatisticsInstitute for Health and Society, Medical College of WisconsinMilwaukee Wisconsin

Funder

National Cancer Institute

National Heart, Lung, and Blood Institute

Health Resources and Services Administration

Office of Naval Research

Alexion Pharmaceuticals

Medical College of Wisconsin

Astellas Pharma US

AstraZeneca

Celgene

Fred Hutchinson Cancer Research Center

Genentech

Genzyme

Gilead Sciences

Health Research

Roswell Park Cancer Institute

Leukemia and Lymphoma Society

MedImmune

Novartis Pharmaceuticals Corporation

Onyx Pharmaceuticals

Otsuka America Pharmaceutical

Patient-Centered Outcomes Research Institute

Seattle Genetics

St. Baldrick's Foundation

University of Minnesota

WellPoint

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3